Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

UnitedHealth must pay doctors $60M after losing lawsuit against TeamHealth

A UHC spokesperson said the insurance giant is planning an "immediate" appeal.

Judge halts Biden administration's worker vaccine mandate

More than 17 million healthcare workers and 67,000 providers are likely affected by the now-paused instruction.

healthcare value value-based care money dollar

Top states with the most affordable healthcare

Americans are paying more than ever for healthcare, but how much depends on where they live.

Thumbnail

DOJ investigating Oak Street Health for possible False Claims Act violations

The Chicago-based chain of 100-plus Medicare clinics said it recently received a civil investigative demand.

States sue Biden over COVID vaccine mandate

President Joe Biden is facing major backlash following a COVID-19 vaccine mandate.

 

Thumbnail

Justice Department charges Arkansas man in $100M COVID scam

An Arkansas man who owned or managed several diagnostic testing laboratories has been indicted on healthcare fraud charges in connection with $100 million in false billings.

 

Thumbnail

Many nationally recognized cancer centers are not complying with price transparency rules

The lack of cooperation may be hindering efforts to rein in cancer costs and improve affordability, oncology experts explained recently.

UnitedHealthcare UHC UnitedHealth

UnitedHealthcare sues hospital staffing firm TeamHealth, alleging $100M in fraudulent claims

The insurance giant alleged that 62% of claims involving the highest-paying ED codes didn't match medical records, according to documents filed Wednesday.

Displaying 673 - 680 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup